[1] 中华医学会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志,2000,8(6):324-329. [2] KRASTER Z,ANTONOV K,JELEV DT. The prevention of an expected hepatic flare in HBe negative patients after lamivudime discontinuation[J]. J Gastrointestin liver Dis,2006,15(4):389-391. [3] FUNG SK,LOK AS. Management of hepatitis B patients with antiviral resistance[J]. Antivir Ther,2004,9(6):1013-1026. [4] WESTLAND CE,YANG H,DELANEY WE 4th,et al.Activity of adeforir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients[J]. J Viral Hepat,2005,12:67-73. [5] 王宇明,陈耀凯,张大志,等. 阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎临床研究[J]. 中华肝脏病杂志,2006,14(11):803-805. [6] SCHIFF E,LAI CL,Hadziyannis S,et al. Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine resistant hepatitis B:final long-term results[J]. Liver Transpl,2007,13(3):349-360. [7] RAPTI I,DIMOU E,MITSOULA P,et al. Adding on versus switching to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B[J]. Hepatology,2007,45(2):307-313. [8] YEON JE,YOO W,HONG SP,et al. Resistance to adeforir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adeforir dipivoxil[J]. Cut,2006,55(10):1488-1495. [9] MARCELLIN P,ASSLAH T,BOYER N.Treatment of chronic hepatitis B[J]. J Viral Hepat,2005,12(4):333-345. [10] LOK AS,MCMAHON BJ. Chronic hepatitis B[J].Hepatology,2007,45:507-539. |